Add like
Add dislike
Add to saved papers

Quantifying Corneal Topographic Astigmatism (CorT Total) in Keratoconic Eyes.

PURPOSE: To determine optimal corneal regions from which to derive corneal topographic astigmatism (CorT) in kerato-conic eyes.

METHODS: In this retrospective study, potential measures of corneal astigmatism are calculated from raw total corneal power data (179 eyes from 124 patients) from a corneal tomographer. The measures are derived from annular corneal regions varying in both extent and center position, and evaluated according to the variability of the ocular residual astigmatism (ORA) in the cohort. This variability is quantified by the ORArms, which is the root-mean-squared distance of the ORAs from their summated vector mean in double angle space. The lower the ORArms, the better the corneal astigmatism measure corresponds to manifest refractive cylinder.

RESULTS: Corneal astigmatism measures derived from regions centered on corneal vertex had ORArms values (mild: 1.07 diopters [D], moderate: 1.61 D, severe: 2.65 D) as low or lower than other measures derived from regions centered on thinnest point, corneal apex (front or back), or pupil center. Corneal astigmatism measures derived from a region centered 30% of the way toward thinnest point from corneal vertex appeared to have even lower ORArms values (mild: 1.05 D, moderate: 1.45 D, severe: 2.56 D). None of the corneal astigmatism measures corresponded closely with manifest refractive cylinder for severe keratoconus (ORArms > 2.50 D).

CONCLUSIONS: For keratoconic eyes, the CorT should be derived from an annular region centered 30% of the way toward thinnest point from corneal vertex, although when the keratoconus is mild, a standard corneal-vertex-centered CorT performs just as well. [ J Refract Surg . 2023;39(3):206-213.] .

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app